Cagrilintide vs Retatrutide
Evidence tier, human-evidence strength, regulatory status, and hype-vs-data — side by side.
On published evidence, Retatrutide currently grades higher (B-tier vs C-tier). That reflects evidence maturity, not that it's “better” for any person or goal.
- Stronger human evidence: Retatrutide
- More hype than data: neither stands out
| cagrilintide | retatrutide | |
|---|---|---|
| Class | GLP-1 & incretin receptor agonists | GLP-1 & incretin receptor agonists |
| Regulatory status | Investigational | Investigational |
| Candidate sources | 0 | 0 |
| Top study types (candidate) | — | — |
| Translation risk | pending review | pending review |
Cagrilintide vs Retatrutide: FAQ
Is Cagrilintide better than Retatrutide?
On published evidence, Retatrutide currently grades higher (B-tier vs C-tier). That reflects evidence maturity, not that it's “better” for any person or goal. Neither is a recommendation to use anything; this compares the state of the evidence only.
What's the difference between Cagrilintide and Retatrutide?
Cagrilintide is investigational and sits at the “Clinical trials” evidence stage; Retatrutide is investigational and sits at “Clinical trials.”
Which has stronger human evidence, Cagrilintide or Retatrutide?
Retatrutide has the stronger human-evidence signal of the two on our scale.
Research reference only. Not medical advice, treatment instructions, or a purchase recommendation. Consult a licensed professional.